Skip to main content
Cureus logoLink to Cureus
. 2025 Sep 29;17(9):e93491. doi: 10.7759/cureus.93491

Nitrogen Oxide Inhalation Lung Injury From an Industrial Explosion: A Case Report and Review of the Literature

Hitokazu Tsukao 1,
Editors: Alexander Muacevic, John R Adler
PMCID: PMC12571024  PMID: 41170255

Abstract

An industrial explosion released nitrogen oxide, which a 43-year-old man inhaled at work. He developed cough and exertional dyspnea without hypoxemia, and chest computed tomography obtained two days after exposure showed poorly defined centrilobular ground-glass nodules predominantly in the lingular and lower lobes. Bronchoalveolar lavage revealed an increased total cell count with mild lymphocytosis. Transbronchial lung biopsy demonstrated type II pneumocyte hyperplasia, mural thickening with focal fibrosis, and fibrin deposition consistent with centri-acinar dominant alveolitis. Supportive care without corticosteroids led to clinical and radiologic resolution.

This case highlights the latent onset pattern after nitrogen oxide inhalation and provides clinicoradiologic-pathologic correlation for a mild presentation, suggesting that careful observation may be reasonable when oxygenation is preserved and no progression is observed.

Keywords: accidents, industrial, lung injuries, nitrogen oxides, pathology, radiology

Introduction

Nitrogen oxides (NOx) are toxic gases generated during nitric acid decomposition, industrial explosions or fires, and metal surface treatment or oxidation processes. In agriculture, NOx exposure has long been recognized as “silo-filler’s disease” [1,2].

Inhalation typically causes cough, dyspnea, and fever after a latent period of several hours up to 72 hours and may progress to acute respiratory distress syndrome (ARDS) in severe cases [3,4]. At the pathophysiological level, NOx generates reactive nitrogen species that damage the alveolar epithelium and capillary endothelium, leading to increased permeability and inflammation. Late complications, including bronchiolitis obliterans, organizing pneumonia, or pulmonary fibrosis, have also been reported [5].

Exposure scenarios are diverse, including industrial explosions, tank-cleaning accidents, and chemical reaction incidents [6-8]. More recently, a single severe case managed with veno-venous extracorporeal membrane oxygenation (VV-ECMO) has also been reported [9]. Radiologically, poorly defined centrilobular nodules and ground-glass opacities are characteristic findings [10].

Most previously reported cases were moderate-to-severe, and fatalities are not uncommon [11]. Corticosteroids are often administered [12], but consensus regarding optimal dose or duration is lacking. Furthermore, therapeutic strategies for mild cases remain uncertain, and spontaneous improvement without corticosteroid therapy has been observed [13,14].

Reports that correlate a mild clinical course with pathological findings are scarce. We present a case of mild NOx inhalation injury following an industrial explosion, in which we were able to demonstrate concordant radiologic and histopathologic features. This case may provide new insights into the diagnosis and management of mild NOx lung injury.

Case presentation

A 43-year-old male chemical plant worker, a non-smoker with no passive smoking exposure, presented after an industrial explosion in July 2018. At the time of the accident, a chemical reaction involving 67.5% nitric acid, 4-t-butylcyclohexanol, and ammonium metavanadate was ongoing. An orange-colored gas cloud was documented in on-site photographs. Without respiratory protection, he entered the site and developed malaise. Approximately three hours later, he was transported to the emergency department. Initial chest CT showed no abnormalities, and he was discharged home.

On days 1-2 (18-42 hours after exposure), cough and dyspnea worsened. Chest radiography revealed patchy bilateral opacities, and high-resolution computed tomography (HRCT) demonstrated poorly defined centrilobular ground-glass nodules in the lingular and lower lobes (Figure 1).

Figure 1. Radiographic and HRCT findings of nitrogen oxide inhalation injury.

Figure 1

(A) Chest radiograph on Day 0 showing no abnormalities. (B) Chest radiograph on Day 2 demonstrating new patchy bilateral opacities (arrows). (C) HRCT on Day 0 showing normal lung fields. (D) HRCT on Day 2 revealing poorly defined centrilobular ground-glass nodules in the lingula and bilateral lower lobes (circle).

HRCT: high-resolution computed tomography

On admission, vital signs were stable (peripheral oxygen saturation (SpO₂) 98% on room air). Laboratory testing revealed leukocytosis with a left shift, elevated C-reactive protein (CRP), and mild increases in lactate dehydrogenase (LDH) and creatine phosphokinase (CPK), while angiotensin-converting enzyme (ACE) and soluble interleukin-2 receptor (sIL-2R) levels were within normal limits (Table 1).

Table 1. Laboratory and bronchoalveolar lavage findings on admission.

Reference ranges are shown for each parameter.

ACE, Angiotensin-converting enzyme; ALP, Alkaline phosphatase; ALT, Alanine aminotransferase; AST, Aspartate aminotransferase; BAL, Bronchoalveolar lavage; BNP, Brain natriuretic peptide; BUN, Blood urea nitrogen; CPK, Creatine phosphokinase; CRP, C-reactive protein; FCOHb, Fractional carboxyhemoglobin; FiO₂, Fraction of inspired oxygen; γ-GTP, Gamma-glutamyl transpeptidase; Hb, Hemoglobin; Hct, Hematocrit; KL-6, Krebs von den Lungen-6; LDH, Lactate dehydrogenase; Na, Sodium; K, Potassium; Plt, Platelet count; RBC, Red blood cell count; sIL-2R, Soluble interleukin-2 receptor; SpO₂, Peripheral oxygen saturation; TP, Total protein; WBC, White blood cell count

Parameter Result Reference range
WBC 11,690 /µl 3,500–9,000 /µl
Neutrophils (%) 77.1 % 40–70 %
Eosinophils (%) 1.8 % 1–6 %
Basophils (%) 0.3 % 0–1 %
Monocytes (%) 8.1 % 2–8 %
Lymphocytes (%) 12.7 % 20–45 %
RBC 4.78 ×10^6 /µl 4.10–5.30 ×10^6 /µl (M)
Hemoglobin (Hb) 14.8 g/dl 13.5–17.5 g/dl (M)
Hematocrit (Hct) NA 40–50 % (M)
Platelets (Plt) 28.0 ×10^4 /µl 150–350 ×10^3 /µl
D-dimer 0.20 µg/l <0.5 µg/ml
FiO₂ 21 % 21 % (room air)
pH Error (unknown) 7.35–7.45
pCO₂ 34.2 mmHg 35–45 mmHg
pO₂ 91.9 mmHg 80–100 mmHg
Lactate 7.0 mg/dl 4.5–19.8 mg/dl (0.5–2.2 mmol/L)
FCOHb 0.9 % <2 %
TP 6.5 g/dl 6.6–8.1 g/dl
Albumin 3.3 g/dl 4.1–5.1 g/dl
BUN 0.62 mg/dl 8–20 mg/dl
Creatinine 15.4 mg/dl 0.65–1.07 mg/dl (M)
Na 139 mEq/L 138–145 mEq/L
K 4.3 mEq/L 3.6–4.8 mEq/L
T-Bil 1.3 mg/dl 0.2–1.2 mg/dl
ALP 195 IU/L 106–322 IU/L
AST 17 IU/L 13–33 IU/L
ALT 16 IU/L 8–42 IU/L
LDH 218 IU/L 124–222 IU/L
γ-GTP 14 IU/L 13–64 IU/L
CPK 275 IU/L 45–163 IU/L
BNP <5.8 pg/ml <18.4 pg/ml
CRP 1.80 mg/dl <0.3 mg/dl
KL-6 164.2 U/ml <500 U/ml
SP-A 32.1 ng/ml <43.8 ng/ml
SP-D 65.5 ng/ml <110 ng/ml
ACE 7.0 U/L (37℃) 8.3–21.4 U/L
sIL-2R 348.3 U/ml 122–496 U/ml
BAL Recovery 106/150 ml ≥30 %
BAL TCC 5.12 ×10^5 /ml 1–2 ×10^5 /ml
BAL Neutrophils (%) 6.0 % <3 %
BAL Eosinophils (%) 7.0 % <1 %
BAL Lymphocytes (%) 36.0 % 10–15 %
BAL Macrophages (%) 51.0 % 85–95 %
BAL CD4/CD8 ratio 3.04 1.0–3.5
BAL Cytology Class I Class I (normal)
BAL Culture Normal flora

Bronchoscopy revealed no endobronchial abnormalities. Bronchoalveolar lavage fluid was turbid and yellowish, with an increased cell count but negative cultures. Transbronchial lung biopsy demonstrated type II pneumocyte hyperplasia and alveolar wall thickening with fibrosis. Lesions were predominantly distributed around muscular pulmonary arteries, suggesting an airway-centered pattern. Intra-alveolar eosinophilic material consistent with fibrin deposition and early organization was also identified. Collectively, these findings supported a diagnosis of centriacinar-dominant mural alveolitis with focal fibrin deposition (Figure 2).

Figure 2. Histopathological findings from transbronchial lung biopsy.

Figure 2

(A, C) Alveolar septal thickening with type II pneumocyte hyperplasia adjacent to a muscular pulmonary arteriole (hematoxylin and eosin stain, ×200). (B) Thyroid transcription factor-1 (TTF-1) staining positive in hyperplastic alveolar epithelial cells. (D) Intra-alveolar eosinophilic material consistent with fibrin deposition and early organization.

The patient was managed supportively without corticosteroids. Oxygenation remained stable throughout hospitalization. Radiographic opacities gradually improved, and he was discharged on day 9. He subsequently developed transient depressive symptoms, which improved with psychiatric intervention. These psychiatric manifestations were interpreted as stress-related reactions to the industrial accident rather than direct toxic effects of NOx exposure. Follow-up CT scans on days 15 and 45 showed marked resolution (Figure 3).

Figure 3. Clinical course .

Figure 3

Follow-up CT on day 45 after exposure demonstrating resolution of the previously noted centrilobular ground-glass opacities.

Discussion

Inhalational injuries may be caused by gases such as chlorine, phosgene, sulfur dioxide, hydrogen sulfide, NOx, ozone, and ammonia [15]. Highly water-soluble gases (chlorine, ammonia, sulfur dioxide) tend to dissolve in the upper airway, whereas poorly soluble gases (phosgene, NOx, ozone) reach the lower respiratory tract and exert delayed effects [16]. Accordingly, highly soluble gases cause acute upper-airway symptoms immediately, while poorly soluble gases cause delayed onset symptoms after a latent period. In our patient, initial imaging was normal, but infiltrates appeared on day 2, consistent with the typical pathophysiology of NOx injury.

The most severe complication is ARDS, usually developing within 24 hours of high-concentration exposure [3]. Late complications, such as organizing pneumonia, bronchiolitis obliterans, and pulmonary fibrosis, have also been documented [5,13]. Thus, attention is required not only in the acute phase but also during long-term follow-up.

Previous reviews have summarized English-language cases, but numerous cases have also been reported in Japanese literature [12]. To contextualize our case within the broader spectrum of NOx inhalation injury, we reviewed 64 cases reported between 1978 and 2018, encompassing both international and domestic reports while excluding duplicates and abstracts (Table 2) [17-26].

Table 2. Reported cases of NOx inhalation injury, 1978–2018.

This table summarizes reported cases of nitrogen oxide (NOx) inhalation injury published in the English- and Japanese-language literature. Twenty-nine references were included; duplicates and abstracts were excluded. A severe case was defined as PaO₂ < 60 mmHg on room air or the requirement for supplemental oxygen at the initial assessment.

Rows marked with an asterisk (*) indicate cases cited from secondary Japanese sources because the original pre-Internet articles were inaccessible.

Secondary sources used for data abstraction:

Araki Y (1983), Akamine Y (1986): Data abstracted from secondary source: Osakabe Y, et al. [25]

Ikegami K (1998), Kaneko Y (2006), Kikuchi Y (2006), Hino H (2009), Ito T (2009), Kawaura T (2009): Data abstracted from secondary source: Hayashi M, et al. [26]

Original reports are cited whenever accessible.

WBC, white blood cell count; RBC, red blood cell count; Hb, hemoglobin; Hct, hematocrit; Plt, platelet count; PSL, prednisolone; mPSL, methylprednisolone; ECMO, extracorporeal membrane oxygenation; NA, not available

Author (years) Number Age Sex Severity Occupation Steroid use Mechanical ventilation Outcome/prognosis
Matsuzaki Y (1978) [17] 1 54 M severe boiler maintenance Yes No survived
Horvath (1978) [14] 2 63 M NA non-smoking daily farmer Yes No survived
19 M severe employee of munitions Yes No survived
Araki Y (1983) [*] 1 48 M mild automobile mechanic Yes No survived
Tamura N (1985) [18] 1 50 M mild iron works No No survived
Akamine Y (1986) [*] 1 52 M severe metal refining Yes Yes survived
Kitahara (1988) [19] 1 33 M severe metal plating factory Yes No survived
Iwami F (1988) [20] 1 20 M severe electric welder Yes No survived
Shiramine K (1989) [21] 1 52 M NA daily farmer Yes Yes survived
Hajela (1990) [3] 3 36 M severe pulp-mill worker No Yes died
44 M severe pulp-mill worker No Yes died
21 M severe pulp-mill worker No No died
Zwemer (1992) [22] 20 NA NA 10 severe NA Yes(7 cases)/No(3 cases) NA 4 died/6 survived
NA NA 10 mild NA Yes(6 cases)/No(4 cases) NA 10 survived
Suzuki K (1993) [23] 6 41 M severe ship repairing Yes No survived
60 M severe ship repairing Yes No survived
48 M NA ship repairing NA No survived
53 M NA ship repairing NA No survived
39 M NA ship repairing NA No survived
25 M mild ship repairing NA No survived
Shimatsu Y (1996) [24] 4 47 M severe iron works Yes No survived
53 M severe iron works Yes No survived
57 M mild iron works No No survived
40 M mild iron works No No survived
Bur (1997) [11] 1 56 M severe cleaning staff Yes Yes died
Ikegami K (1998) [*] 2 NA NA mild metal plating factory NA Yes survived
NA NA NA metal plating factory NA Yes survived
Osakabe Y (2000) [25] 1 64 M severe metal plating factory Yes Yes survived
Kaneko Y (2006) [*] 3 65 M severe pump demolition work Yes Yes survived
51 M severe pump demolition work Yes No survived
58 M mild pump demolition work Yes No survived
Kikuchi Y (2006) [*] 1 62 M severe diamond factory work No Yes survived
Tanaka (2007) [10] 3 65 M severe factory work Yes Yes survived
52 M severe factory work Yes No survived
37 F severe factory work Yes No survived
Hino H (2009) [*] 1 42 M NA metalworking industry Yes Yes survived
Ito T (2009) [*] 1 68 M NA metal plating work Yes No survived
Kawaura T (2009) [*] 1 21 M NA shipbuilding industry Yes Yes survived
Jayalakshmi (2009) [8] 3 30 M severe cleaning staff Yes Yes survived
35 M mild NA Yes Yes survived
28 M mild NA Yes Yes survived
Murphy (2010) [4] 1 66 M severe tank cleaning Yes NA died
Lee (2014) [5] 1 50 M mild storekeeper Yes No survived
Hayashi M (2014) [26] 1 43 M severe metal plating factory No No survived
Kido Y (2017) [12] 1 50 M severe electroless nickel plating Yes No survived
Present case (2018) 1 42 M mild chemical factory No No survived

In total, 64 cases of NOx inhalation injury have been reported, with a mean age of 46.3 years (based on 42 cases with available demographic data). Severe cases, defined as those with PaO₂ <60 mmHg on room air or requiring supplemental oxygen, accounted for 34 (53.1%), whereas 21 (32.8%) were mild and 9 (14.1%) were unspecified. Overall, 55 patients (85.9%) survived and 9 (14.1%) died.

Our patient thus represents a rare category of steroid-free survival. Importantly, most previously reported survivors received corticosteroid therapy, whereas our case demonstrated full recovery without it, reinforcing the potential for conservative management in carefully monitored mild cases. Compared with previously reported severe or fatal cases, our patient presented with a milder course characterized by preserved oxygenation, radiologic-pathologic correlation, and recovery without corticosteroid therapy. This contrast underscores the clinical spectrum of NOx injury and highlights the importance of individualized management strategies.

More recent reports underscore the broad severity spectrum: dose-dependent severe cases after NO₂ explosion [9], delayed onset after occupational exposure [27], histologically confirmed secondary organizing pneumonia [28], and VV-ECMO-supported survival in severe ARDS [9,11,29]. Additional case reports have described severe lung injury and acute respiratory distress syndrome following nitric acid fume exposure [7,8]. These highlight both the life-threatening potential and the variability of NOx injury. Our case lies at the mild end of this spectrum, emphasizing the need for individualized management.

While steroids are frequently recommended, their optimal regimen remains uncertain. Some authors suggest courses of ≥4 weeks [12], yet mild cases may improve spontaneously. Lee described late-onset bronchiolitis obliterans after nitric acid exposure [5], though whether early steroids would have prevented this remains unclear. Our case suggests that in carefully monitored mild cases with preserved oxygenation, conservative management without steroids may be a reasonable option.

Imaging-pathology correlation is also noteworthy. Tanaka reported centrilobular ground-glass nodules, interlobular septal thickening, and absence of lymphadenopathy as typical HRCT features [10]. Our patient demonstrated similar CT findings, with histology showing centriacinar-dominant mural alveolitis with fibrin, closely matching radiology. Such concordance in a mild case is rarely documented and enhances understanding of NOx pathology.

Conclusions

This case illustrates mild NOx inhalation injury following an industrial explosion, with radiologic and pathologic concordance of centriacinar-dominant mural alveolitis. It is among the very few steroid-free survivors reported. Clinically, this underscores that mild cases may resolve spontaneously, yet vigilance is essential due to potential delayed complications such as bronchiolitis obliterans and pulmonary fibrosis. Long-term follow-up is indispensable.

Acknowledgments

We thank Dr. Isao Ito for valuable guidance on the preparation and presentation of this manuscript, and Dr. Masanori Kitaichi for the detailed pathological assessment.

Disclosures

Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study.

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:

Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.

Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.

Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Author Contributions

Concept and design:  Hitokazu Tsukao

Acquisition, analysis, or interpretation of data:  Hitokazu Tsukao

Drafting of the manuscript:  Hitokazu Tsukao

Critical review of the manuscript for important intellectual content:  Hitokazu Tsukao

References


Articles from Cureus are provided here courtesy of Cureus Inc.

RESOURCES